The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma

The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma

Objective Limited studies have reported the impact of drug-eluting bead transarterial chemoembolization (DEB-TACE) on hepatic fibrosis in hepatocellular carcinoma (HCC). This study evaluated multiple hepatic fibrosis indicators, aiming to comprehensively compare the influence of DEB-TACE and convent...

Full description

Bibliographic Details
Main Authors: Hao Li, Chao Liang, Donglin Kuang, Guohao Huang, Mengfan Zhang, Pengfei Chen, Qingzhu Zheng, Wenze Xu, Jianzhuang Ren, Xinwei Han, Xuhua Duan
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Cancer Biology & Therapy
Subjects:
hepatocellular carcinoma
drug-eluting bead transarterial chemoembolization
conventional transarterial chemoembolization
hepatic fibrosis
safety
Online Access:http://dx.doi.org/10.1080/15384047.2023.2166335

Internet

http://dx.doi.org/10.1080/15384047.2023.2166335

Similar Items